FTY720/Cyclosporine Regimens in De Novo Renal Transplantation: A 1-Year Dose-Finding Study
Open Access
- 12 June 2006
- journal article
- research article
- Published by Elsevier in American Journal of Transplantation
- Vol. 6 (8) , 1848-1857
- https://doi.org/10.1111/j.1600-6143.2006.01404.x
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- FTY720: Sphingosine 1-Phosphate Receptor-1 in the Control of Lymphocyte Egress and Endothelial Barrier FunctionAmerican Journal of Transplantation, 2004
- Protective Effects of Sphingosine 1-Phosphate in Murine Endotoxin-induced Inflammatory Lung InjuryAmerican Journal of Respiratory and Critical Care Medicine, 2004
- Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1Nature, 2004
- Pharmacodynamics, pharmacokinetics, and safety of multiple doses of FTY720 in stable renal transplant patients: a multicenter, randomized, placebo-controlled, phase I studyTransplantation, 2003
- Five preventable causes of kidney graft loss in the 1990s: A single-center analysis1Kidney International, 2002
- FTY720: targeting G-protein-coupled receptors for sphingosine 1-phosphate in transplantation and autoimmunityCurrent Opinion in Immunology, 2002
- The Immune Modulator FTY720 Targets Sphingosine 1-Phosphate ReceptorsJournal of Biological Chemistry, 2002
- Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor AgonistsScience, 2002
- FTY720 Immunosuppression Impairs Effector T Cell Peripheral Homing Without Affecting Induction, Expansion, and MemoryThe Journal of Immunology, 2000
- The Banff 97 working classification of renal allograft pathologyKidney International, 1999